21 January 2023 : Database Analysis
NFYAv1 is a Tumor-Promoting Transcript Associated with Poor Prognosis of Hepatocellular Carcinoma
Zigang Li1ABCDEF*, Chengshan You2ABDF, Jun Huang3CD, Ming Zhang1BEDOI: 10.12659/MSM.938410
Med Sci Monit 2023; 29:e938410
Figure 1 HCC patients with elevated NFYA expression had significantly worse survival(A–F) K-M analysis for DSS (B, D, F) and PFS (A, C, E) comparison was performed. Patients with primary HCC in TCGA were classified into 2 groups by the median NFYA (A, B), NFYB (C, D) or NFYC (E, F) expression. (G) NFYA protein expression in normal liver and HCC tissues. IHC staining images were obtained from the HPA, from the following links: https://www.proteinatlas.org/ENSG00000001167-NFYA/tissue/liver and https://www.proteinatlas.org/ENSG00000001167-NFYA/pathology/liver+cancer#ihc.